Legal & General Group
NVRO

Legal & General Group’s NEVRO CORP. NVRO Stock Holding History

Legal & General Group’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,067
Closed -$17.9K – 3592
2025
Q1 		$17.9K Hold
3,067
– – ﹤0.01% 2978
2024
Q4 		$11.4K Hold
3,067
– – ﹤0.01% 3225
2024
Q3 		$17.1K Sell
3,067
-20,978
-87% -$147K ﹤0.01% 3111
2024
Q2 		$202K Sell
24,045
-12,889
-35% -$137K ﹤0.01% 2665
2024
Q1 		$533K Hold
36,934
– – ﹤0.01% 2400
2023
Q4 		$795K Sell
36,934
-73,122
-66% -$1.3M ﹤0.01% 2278
2023
Q3 		$2.12M Buy
110,056
+21,058
+24% +$449K ﹤0.01% 1877
2023
Q2 		$2.26M Buy
88,998
+14,319
+19% +$413K ﹤0.01% 1867
2023
Q1 		$2.7M Buy
74,679
+7,193
+11% +$253K ﹤0.01% 1741
2022
Q4 		$2.67M Sell
67,486
-36
-0.1% -$1.5K ﹤0.01% 1735
2022
Q3 		$3.15M Sell
67,522
-2,853
-4% -$132K ﹤0.01% 1615
2022
Q2 		$3.08M Buy
70,375
+14,509
+26% +$798K ﹤0.01% 1663
2022
Q1 		$4.04M Sell
55,866
-14,014
-20% -$1.01M ﹤0.01% 1639
2021
Q4 		$5.67M Buy
69,880
+4,615
+7% +$462K ﹤0.01% 1505
2021
Q3 		$7.59M Buy
65,265
+11,980
+22% +$1.57M ﹤0.01% 1321
2021
Q2 		$8.84M Sell
53,285
-15,421
-22% -$2.41M ﹤0.01% 1239
2021
Q1 		$9.58M Buy
68,706
+10,468
+18% +$1.71M ﹤0.01% 1229
2020
Q4 		$10.1M Buy
58,238
+5,094
+10% +$825K ﹤0.01% 1107
2020
Q3 		$7.4M Sell
53,144
-1,276
-2% -$170K ﹤0.01% 1155
2020
Q2 		$6.5M Buy
54,420
+34,394
+172% +$4.08M ﹤0.01% 1193
2020
Q1 		$2.02M Sell
20,026
-1,374
-6% -$165K ﹤0.01% 1581
2019
Q4 		$2.52M Buy
21,400
+1,280
+6% +$127K ﹤0.01% 1687
2019
Q3 		$1.73M Buy
20,120
+6,413
+47% +$485K ﹤0.01% 1786
2019
Q2 		$889K Buy
13,707
+702
+5% +$43.7K ﹤0.01% 1989
2019
Q1 		$813K Buy
13,005
+119
+0.9% +$5.6K ﹤0.01% 2030
2018
Q4 		$502K Buy
12,886
+3,065
+31% +$136K ﹤0.01% 2114
2018
Q3 		$559K Hold
9,821
– – ﹤0.01% 2112
2018
Q2 		$785K Sell
9,821
-633
-6% -$52.5K ﹤0.01% 1993
2018
Q1 		$906K Sell
10,454
-1,831
-15% -$148K ﹤0.01% 1924
2017
Q4 		$851K Buy
12,285
+896
+8% +$71.7K ﹤0.01% 1950
2017
Q3 		$1.03M Buy
11,389
+602
+6% +$51.5K ﹤0.01% 1855
2017
Q2 		$806K Buy
10,787
+2,650
+33% +$212K ﹤0.01% 1909
2017
Q1 		$760K Buy
8,137
+418
+5% +$37.9K ﹤0.01% 1901
2016
Q4 		$561K Buy
7,719
+2,441
+46% +$209K ﹤0.01% 1948
2016
Q3 		$544K Buy
5,278
+208
+4% +$18.8K ﹤0.01% 1653
2016
Q2 		$365K Buy
5,070
+976
+24% +$66.2K ﹤0.01% 1500
2016
Q1 		$228K Buy
4,094
+912
+29% +$53.8K ﹤0.01% 1691
2015
Q4 		$212K Buy
3,182
+1,417
+80% +$75.9K ﹤0.01% 1723
2015
Q3 		$80K Buy
1,765
+108
+7% +$5.23K ﹤0.01% 2175
2015
Q2 		$88K Buy
1,657
+1,428
+624% +$72.7K ﹤0.01% 2214
2015
Q1 		$11K Buy
+229
New +$9.94K ﹤0.01% 2764

Other funds holding NVRO

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Legal & General Group's NVRO Position: Q2 2025 in Review

Legal & General Group sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 3,067 shares — an estimated $17.9K sold.

Legal & General Group first reported a position in NVRO in Q1 2015 and held it in 41 quarters. The position peaked at $10.1M in Q4 2020. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

  • Legal & General Group reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 3,067 NEVRO CORP. shares in Q2 2025, an estimated $17.9K.
  • Legal & General Group first reported a position in NEVRO CORP. in Q1 2015 and held it in 41 quarters.
  • Legal & General Group's NEVRO CORP. position peaked at $10.1M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.